“…Don is the father of the field of drug repurposing, which proposes new uses for existing approved drugs (e.g., Weeber et al, 2003; Yang et al, 2017). Prediction of adverse drug effects follows a similar type of logic (e.g., Shang et al, 2014; Hristovski et al, 2016), as does detection of co-morbidities and other relations among drugs, diseases and genes (Frijters et al, 2010; Ding et al, 2013; Vos et al, 2014).…”